Prescott Group Capital Management L.L.C. Makes New $1.61 Million Investment in Addus HomeCare Corporation $ADUS

Prescott Group Capital Management L.L.C. purchased a new position in Addus HomeCare Corporation (NASDAQ:ADUSFree Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 15,000 shares of the company’s stock, valued at approximately $1,611,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of ADUS. Larson Financial Group LLC grew its position in Addus HomeCare by 133.3% in the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock worth $28,000 after purchasing an additional 136 shares during the last quarter. Private Trust Co. NA grew its position in Addus HomeCare by 65.5% in the 4th quarter. Private Trust Co. NA now owns 283 shares of the company’s stock worth $30,000 after purchasing an additional 112 shares during the last quarter. AlphaQuest LLC acquired a new stake in Addus HomeCare in the 3rd quarter worth $37,000. Wexford Capital LP acquired a new stake in Addus HomeCare in the 3rd quarter worth $41,000. Finally, State of Wyoming acquired a new stake in Addus HomeCare in the 2nd quarter worth $47,000. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Addus HomeCare

In other news, EVP Sean Gaffney sold 817 shares of the firm’s stock in a transaction dated Tuesday, February 24th. The shares were sold at an average price of $106.98, for a total transaction of $87,402.66. Following the completion of the transaction, the executive vice president directly owned 20,522 shares of the company’s stock, valued at approximately $2,195,443.56. This trade represents a 3.83% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO R Dirk Allison sold 4,988 shares of the firm’s stock in a transaction dated Tuesday, February 24th. The stock was sold at an average price of $106.98, for a total transaction of $533,616.24. Following the transaction, the chief executive officer directly owned 185,514 shares of the company’s stock, valued at $19,846,287.72. The trade was a 2.62% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 16,788 shares of company stock worth $1,785,633 in the last ninety days. Company insiders own 4.50% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have issued reports on ADUS shares. Stephens decreased their price target on shares of Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 25th. Wall Street Zen lowered shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, March 21st. KeyCorp restated an “overweight” rating on shares of Addus HomeCare in a research report on Wednesday, February 25th. Weiss Ratings restated a “hold (c+)” rating on shares of Addus HomeCare in a research report on Wednesday, January 21st. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a report on Wednesday, February 25th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $131.22.

Check Out Our Latest Research Report on ADUS

Addus HomeCare Price Performance

NASDAQ:ADUS opened at $93.76 on Thursday. The company has a 50-day moving average of $96.10 and a 200-day moving average of $105.73. The company has a market capitalization of $1.75 billion, a price-to-earnings ratio of 17.33, a PEG ratio of 1.27 and a beta of 0.92. Addus HomeCare Corporation has a 52 week low of $89.76 and a 52 week high of $124.43. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.83 and a current ratio of 1.83.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last released its quarterly earnings data on Monday, May 4th. The company reported $1.62 EPS for the quarter, topping analysts’ consensus estimates of $1.52 by $0.10. The company had revenue of $363.50 million during the quarter, compared to the consensus estimate of $366.41 million. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. The firm’s revenue for the quarter was up 7.7% compared to the same quarter last year. During the same period last year, the firm earned $1.42 EPS. As a group, equities research analysts anticipate that Addus HomeCare Corporation will post 6.24 earnings per share for the current fiscal year.

About Addus HomeCare

(Free Report)

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

See Also

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUSFree Report).

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.